Anders Lilja

Summary

Affiliation: Novartis Institutes for BioMedical Research

Publications

  1. doi request reprint The next generation recombinant human cytomegalovirus vaccine candidates-beyond gB
    Anders E Lilja
    Novartis Vaccines and Diagnostics, Inc, Cambridge, MA 02139, United States
    Vaccine 30:6980-90. 2012
  2. pmc Mutations at positions 186 and 194 in the HA gene of the 2009 H1N1 pandemic influenza virus improve replication in cell culture and eggs
    Pirada Suphaphiphat
    Novartis Vaccines and Diagnostics, Cambridge, MA, USA
    Virol J 7:157. 2010

Collaborators

  • Pirada Suphaphiphat
  • Annunziata B Tuccino
  • Mithra Rothfeder
  • Gene Palmer
  • Kara Balabanis
  • Heidi Trusheim
  • Melissa Sackal
  • Ethan Settembre
  • Peter W Mason
  • Terika Spencer
  • Bjoern Keiner
  • Philip R Dormitzer
  • Michael Franti
  • Christian W Mandl
  • Armin Hekele
  • Stefania Crotta

Detail Information

Publications2

  1. doi request reprint The next generation recombinant human cytomegalovirus vaccine candidates-beyond gB
    Anders E Lilja
    Novartis Vaccines and Diagnostics, Inc, Cambridge, MA 02139, United States
    Vaccine 30:6980-90. 2012
    ..These data show the clinical feasibility of a recombinant HCMV vaccine. We discuss areas for potential improvements in the next generation of vaccine candidates...
  2. pmc Mutations at positions 186 and 194 in the HA gene of the 2009 H1N1 pandemic influenza virus improve replication in cell culture and eggs
    Pirada Suphaphiphat
    Novartis Vaccines and Diagnostics, Cambridge, MA, USA
    Virol J 7:157. 2010
    ..Thus, we have demonstrated that molecular cloning of members of a quasispecies can help in selection of seed viruses for vaccine manufacture...